- Home
- RAND vs PEPG Comparison
RAND vs PEPG Comparison
Compare RAND & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAND
- PEPG
- Stock Information
- Founded
- RAND 1969
- PEPG 2018
- Country
- RAND United States
- PEPG United States
- Employees
- RAND N/A
- PEPG N/A
- Industry
- RAND Finance: Consumer Services
- PEPG Biotechnology: Pharmaceutical Preparations
- Sector
- RAND Finance
- PEPG Health Care
- Exchange
- RAND Nasdaq
- PEPG Nasdaq
- Market Cap
- RAND 57.6M
- PEPG 52.4M
- IPO Year
- RAND N/A
- PEPG 2022
- Fundamental
- Price
- RAND $15.48
- PEPG $1.40
- Analyst Decision
- RAND
- PEPG Buy
- Analyst Count
- RAND 0
- PEPG 3
- Target Price
- RAND N/A
- PEPG $7.67
- AVG Volume (30 Days)
- RAND 6.1K
- PEPG 169.8K
- Earning Date
- RAND 08-05-2025
- PEPG 08-07-2025
- Dividend Yield
- RAND 7.47%
- PEPG N/A
- EPS Growth
- RAND 39.77
- PEPG N/A
- EPS
- RAND 3.12
- PEPG N/A
- Revenue
- RAND $8,499,970.00
- PEPG N/A
- Revenue This Year
- RAND N/A
- PEPG N/A
- Revenue Next Year
- RAND N/A
- PEPG N/A
- P/E Ratio
- RAND $4.98
- PEPG N/A
- Revenue Growth
- RAND 12.52
- PEPG N/A
- 52 Week Low
- RAND $14.01
- PEPG $0.88
- 52 Week High
- RAND $31.89
- PEPG $19.30
- Technical
- Relative Strength Index (RSI)
- RAND 42.20
- PEPG 48.28
- Support Level
- RAND $15.15
- PEPG $1.37
- Resistance Level
- RAND $15.75
- PEPG $1.49
- Average True Range (ATR)
- RAND 0.52
- PEPG 0.09
- MACD
- RAND 0.14
- PEPG -0.00
- Stochastic Oscillator
- RAND 36.67
- PEPG 38.46
About RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. The company's investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.